Literature DB >> 10099112

Mucosal dendritic cells and immunodeficiency viruses.

M Pope1.   

Abstract

Dendritic cells [DCs] have been implicated in the pathogenesis of human immunodeficiency virus type 1 (HIV-1). When skin was used as a model for mucosae, the cutaneous DC-T cell milieu allowed the growth of HIV-1 and much of the newly produced virus could be detected in multinucleated DC-T cell syncytia. Such virus replication occurs irrespective of the genetic subtype, the syncytium- and non-syncytium-inducing capacities of the viruses, and whether they are classified as T cell- or macrophage-tropic. Similar DC-syncytia have been identified within the mucosal surfaces of the tonsillar tissue of HIV-1-infected persons. More recently, it was demonstrated that DC-T cell mixtures from the skin, mucosae, and blood of healthy macaques similarly support the replication of simian immunodeficiency virus. In both the human and monkey systems, active virus replication requires the presence of both DCs and T cells. Further studies using the macaque model are underway to elucidate the role of DCs in the transmission and spread of HIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 10099112     DOI: 10.1086/314798

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Authors:  Franck Lemiale; Wing-pui Kong; Levent M Akyürek; Xu Ling; Yue Huang; Bimal K Chakrabarti; Michael Eckhaus; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

3.  Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.

Authors:  Mark S Sundrud; Scott E Vancompernolle; Karla A Eger; Tullia C Bruno; Arun Subramaniam; Srinivas Mummidi; Sunil K Ahuja; Derya Unutmaz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

4.  GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.

Authors:  Ruizhong Shen; Ernesto R Drelichman; Diane Bimczok; Christina Ochsenbauer; John C Kappes; Jamie A Cannon; Daniela Tudor; Morgane Bomsel; Lesley E Smythies; Phillip D Smith
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 5.  Early HIV-1 target cells in human vaginal and ectocervical mucosa.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2010-12-01       Impact factor: 3.886

6.  The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cellsand T cells.

Authors:  D Messmer; R Ignatius; C Santisteban; R M Steinman; M Pope
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells.

Authors:  C B Huang; K A Emerson; O A Gonzalez; J L Ebersole
Journal:  Oral Microbiol Immunol       Date:  2009-10

9.  Infection of the choroid plexus by feline immunodeficiency virus.

Authors:  D C Bragg; T A Childers; M B Tompkins; W A Tompkins; R B Meeker
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

10.  Dendritic cell activation and maturation induced by mucosal fluid from women with bacterial vaginosis.

Authors:  Elizabeth P St John; Jeff Martinson; Jose A Simoes; Alan L Landay; Gregory T Spear
Journal:  Clin Immunol       Date:  2007-07-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.